PYPD
PolyPid
NASDAQ: PYPD · HEALTHCARE · BIOTECHNOLOGY
$4.53
+2.26% today
Updated 2026-04-29
Market cap
$84.54M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.09
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$12.25
+170.42%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-39.52M | $-23.86M | $-29.02M | $-34.17M | $-8.47M |
| EPS | — | — | — | — | $-2.09 |
| Free cash flow | $-36.08M | $-17.43M | $-22.04M | $-28.09M | — |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
PolyPid trades at $4.53. Our Smart Value Score of 19/100 indicates the stock is weak.
Frequently asked questions
What is PolyPid's stock price?
PolyPid (PYPD) trades at $4.53.
Is PolyPid overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell).
What is the price target of PolyPid (PYPD)?
The analyst target price is $12.25, representing +170.4% upside from the current price of $4.53.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-366.30%
Beta1.46
50D MA$4.35
200D MA$3.93
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—